Acquisition by Aurora Cannabis Inc. ("Aurora") (ACB) (ACB.TO) ( Frankfurt : 21P; WKN: A1C4WM) Acquisition: On April 16, 2019 , Aurora Cannabis Inc. (Aurora) and Hempco announced the companies had entered into a binding letter agreement (the "Letter Agreement") for Aurora to acquire all of the remaining issued and outstanding common shares of Hempco ("Hempco Shares") not already owned. In consideration of the transaction, Aurora has agreed to pay C$1.04 per Hempco Share, payable in common shares of Aurora, reflecting a valuation of approximately C$63.4 million on a fully diluted basis. The full release is available under the Company's SEDAR profile at www.sedar.com. Hempco's board of directors has recommended Hempco shareholders vote in favour of the transaction as they believe that full integration of Hempco with Aurora's global hemp assets will enable accelerated growth, generating additional shareholder value. Revenues: 104% year over year revenue growth to $0.6 million from $0.3 million for Q2 2018 was driven by execution of the Company's five prong strategy with focus on tri-crop utilization. Nisku facility: Hempco is in the process of commissioning production at its new, state-of-the-art Nisku facility, a 56,000 square foot, 2.9 million kg-per-year hemp processing facility. Nisku will be GFSI (Global Food Safety Initiative) Certified when it comes fully online. In anticipation of production coming online, the Company has managed to secure a first LOI for the processing of 300 tonnes of hurd. Diversification: The Company's commitment to innovation continued strong this quarter with the introduction of its new organic protein smoothie product line extension for its PLANET HEMP SUPERFOOD? brand. As well, the Retail Council of Canada voted PLANET HEMP SUPERFOODS? Super-Seeds a finalist for the 2019 Canadian Grand Prix New Products Award.
Aurora will have an exclusive license, with sub-licensing rights to EnWave's REV(TM) technology in the European Union (excluding Portugal) and exclusive options to secure the same rights in South America (excluding Peru) and Australia. Aurora will pay EnWave a royalty on all cannabis products processed using the REV(TM) machinery. Aurora will receive an undisclosed share of royalties derived from any cannabis product dried with REV(TM) technology by sub-licensees in jurisdictions where it holds the exclusive license. Aurora will have a non-exclusive sub-license to the EnWave technology in Canada and will pay EnWave a royalty on cannabis product processed in Canada using REV(TM) machinery.
Fri Apr 26 2019 7:03:38 AM EDT BusinessWire, GlobeNewswire and PR Newswire News Aurora Cannabis Inc ACB:NYSE Aurora Cannabis and EnWave Corporation Enter Global Licensing Arrangements GlobeNewswire 7:00 AM ET Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) and EnWave Corporation (TSX-V:ENW) (FSE:E4U) ("EnWave") announced today that the companies have entered into a royalty-bearing commercial license agreement (the "License"), providing Aurora with the exclusive rights to EnWave's patented Radiant Energy Vacuum (REV(TM)) drying technology for the production of cannabis materials in the European Union, excluding Portugal. Aurora has also secured exclusive license options for both Australia and South America, excluding Peru, exercisable pursuant to minimum REV(TM) machine purchase order requirements. Additionally, Aurora has signed a non-exclusive sub-license (the "Sub-License") to use REV(TM) technology in Canada.
Hallo Leute, bin neu hier und hab mich eben mal ein wenig durch euren chat gelesen. Was mir bei dem Thema Cannabis am meisten Mut nacht ist die Konsumgeilheit auf diesem Planeten. Endlich mal wieder ein Produkt, dass bis zum letzten Winkel der Erde vermarktet werden kann. Es deckt in vielen Bereichen alles ab was das Herz begehrt
: Die Fantasie mit Coke und Pepsi bleibt bestehen !
Coke and Pepsi Could Be CBD Stocks, Too, If They Join the Craze -- Barrons.com BY Dow Jones & Company, Inc. ? 11:11 AM ET 04/26/2019
Demand for CBD and related products is exploding. Piper Jaffray believes major beverage companies -- such as Coca- Cola and PepsiCo ( PEP ) -- and cannabis producers look poised to benefit from this growth, whether they focus on infused beverages or other products that promote wellness goals. The back story. Although Canada legalized cannabis in 2017, the road toward acceptance in the U.S. hasn't been as easy. So far, individual states have taken their own approaches to marijuana legalization.
Read more: CBD Is the New Marijuana. But Don't Buy Into the Craze for Hemp Stocks. However, other cannabis-related products have blazed a trail, with last year's legalization of hemp, and its key ingredient cannabidiol, or CBD. That has opened the door to major retailers selling CBD products, the potential for cannabinoid-based drugs, ongoing expansion for cannabis companies like Aurora Cannabis ( ACB ) , and plenty of interest from investors. The Food and Drug Administration will be taking CBD under further consideration, too. What's new. Piper Jaffray analyst Michael Lavery took a look at the potential for CBD amid rapidly growing demand. "It is a bit like gluten (consumers are unsure what it is), but the opposite: they know they want it," he writes. The FDA is holding a hearing on May 31. While at the moment the FDA doesn't allow CBD to be added to foods or beverages sold interstate, in-state sales that abide by local law may skate by. Even if the FDA doesn't broaden the availability of CBD, Lavery believes big beverage companies like Coca-Cola (KO) and PepsiCo ( PEP ), which have local bottlers in every state, could easily sell CBD beverages legally. While neither beverage giant has stated that it intends to enter the market, CBD is definitely on their radar. HEXO Corp. ( HEXO ) also hinted that it could launch in as many as eight states where it believes CBD-infused products will be legal and in demand.
Looking ahead. Ultimately, Lavery estimates the national market for CBD could be worth between $3 billion and $6 billion in 2020, and as much as $8 billion to $15 billion in five years. Along with more recreational products, like drinks, health-related CBD and other cannabis products are another potentially huge growth area. There are ways for companies to skirt the FDA's focus on CBD products with unsubstantiated health claims, Lavery notes. "For example, CBD and melatonin together could be marketed as a sleep aid, as melatonin already supports a claim that it 'Promotes Relaxation & Sleep,' as on its packaging now. This likely has similar potential applications with caffeine for energy or glucosamine for joint pain, etc.," Lavery says.
Lavery believes companies that are making inroads in CBD -- such as Tilray ( TLRY ) and Canopy Growth ( CGC) also look well-positioned to benefit from this growing market, as well as any other companies that "can supply CBD at scale."
Write to Teresa Rivas at email@example.com
(END) Dow Jones Newswires 04-26-19 1111ET Copyright (c) 2019 Dow Jones & Company, Inc.
: Coke angeblich weiterhin in Gespräch mit Aurora !
Coca-Cola is considering marijuana-infused drinks Posted by Josh Clayton on April 28, 2019 at 7:00
Soda?s overrated, so Coca-Cola?s looking into weed.
Coca-Cola has been eyeing cannabis-infused drinks, according to a statement. The company said Monday that it?s ?closely watching? the use of CBD in ?functional wellness? beverages.
?The space is evolving quickly,? Coca-Cola spokesman Kent Landers told . ?No decisions have been made at this time.?
According to a in BNN Bloomberg, the company is ?in talks? with Aurora Cannabis, a Canadian marijuana producer. While sales in sugary sodas have slowed down, Reuters health drinks are on the rise.
Unlike THC, the compound in cannabis that causes a high, CBD is non-psychoactive. It is believed to have anti-inflammatory, anti-nausea, anti-seizure , and because it doesn?t make the user intoxicated, CBD products are marketed as having some of the benefits of cannabis without the intoxication.
Since Canada just recreational marijuana, manufacturers have been showing more and more interest in producing cannabis-infused products. Reuters calls it a ?testing ground? until the U.S. comes around to legalization.
?Entry into a legalized Canadian market allows them to develop and build a brand while not breaking any laws,? Bruce Campbell, an investor who?s invested in weed producers, told Reuters.
If Coca-Cola does go forward with making weed-infused products, it would be the first non-alcoholic manufacturer to make cannabis-related drinks, which would be pretty dank.
Was mich bei Cannabis Aktien (bei mir Aurora) am meisten sehr zuversichtlich sein lässt ist das Konsumverhalten auf dem Planeten. Endlich mal wieder ein Produkt wo ALLE Kasse machen können. -Wellness und Beautie Branche für die Bonsen -Pharmaindustrie für die Kranken -Konsumindustrie für die Konsumgeile Geselschaft (Szenedrinks,Foodindustrie e.t.c -Textilindustrie für die Ökos -Antiageing und nicht die ganzen Kiffer zu vergessen.
Aurora ist gut aufgestellt und wird wachsen. Ich werde meine Aktien vermutlich lange halten.